TE_30832
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | MIRb |
|---|---|
| TE superfamily | L2-end |
| TE class | SINE |
| Gene | NPIPA2 |
| Class | Annoated |
| Coding | Non-coding |
| Tumor-specific score | 0.01 |
| Counts of samples | TCGA_tumor:1; TCGA_normal:0; GTEx:178 |
| TSS | chr16(+):14747808 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_30832.1 | NPIPA2 | Annoated | Non-coding | Non-coding | chr16(+):14747809,14747865,14748028,14748185,14755192,14755320,14758947,14759046,14759210,14759354,14762312,14762419,14763438,14763498,14763608,14763643,14765003,14765023 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
